These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 31238579)

  • 21. Smad4 and ERK2 stimulated by transforming growth factor beta1 in rhabdomyosarcoma.
    Guo H; Zhang HY; Wang SL; Ye L; Yang GH; Bu H
    Chin Med J (Engl); 2007 Mar; 120(6):515-21. PubMed ID: 17439748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transforming growth factor-β signaling pathway in Marfan's syndrome: a preliminary histopathological study.
    Yuan SM; Ma HH; Zhang RS; Jing H
    Vasa; 2011 Sep; 40(5):369-74. PubMed ID: 21948779
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Loss of Smad signaling in human colorectal cancer is associated with advanced disease and poor prognosis.
    Xie W; Rimm DL; Lin Y; Shih WJ; Reiss M
    Cancer J; 2003; 9(4):302-12. PubMed ID: 12967141
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of the gene transcription and apoptosis mediated by TGF-beta-Smad2/3-Smad4 signaling.
    Yu J; Zhang L; Chen A; Xiang G; Wang Y; Wu J; Mitchelson K; Cheng J; Zhou Y
    J Cell Physiol; 2008 May; 215(2):422-33. PubMed ID: 17960585
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differences in Smad4 expression in human papillomavirus type 16-positive and human papillomavirus type 16-negative head and neck squamous cell carcinoma.
    Báez A; Cantor A; Fonseca S; Marcos-Martinez M; Mathews LA; Muro-Cacho CA; Muñoz-Antonia T
    Clin Cancer Res; 2005 May; 11(9):3191-7. PubMed ID: 15867212
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Augmented cytoplasmic Smad4 induces acceleration of TGF-beta1 signaling in renal tubulointerstitial cells of hereditary nephrotic ICGN mice with chronic renal fibrosis; possible role for myofibroblastic differentiation.
    Goto Y; Manabe N; Uchio-Yamada K; Yamaguchi-Yamada M; Inoue N; Yamamoto Y; Ogura A; Nagano N; Miyamoto H
    Cell Tissue Res; 2004 Feb; 315(2):209-21. PubMed ID: 14615933
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Low expression of transforming growth factor beta-1 in cancer tissue predicts a poor prognosis for patients with stage III rectal cancers.
    Chun HK; Jung KU; Choi YL; Hong HK; Kim SH; Yun SH; Kim HC; Lee WY; Cho YB
    Oncology; 2014; 86(3):159-69. PubMed ID: 24643220
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TGF-beta receptor-mediated signalling through Smad2, Smad3 and Smad4.
    Nakao A; Imamura T; Souchelnytskyi S; Kawabata M; Ishisaki A; Oeda E; Tamaki K; Hanai J; Heldin CH; Miyazono K; ten Dijke P
    EMBO J; 1997 Sep; 16(17):5353-62. PubMed ID: 9311995
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Smad4 and TGF-beta1 expression and clinical significance in bladder transitional cell carcinoma].
    Tang ZY; Yang LY; Zhang YJ; Peng KL; Qi L
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Jun; 31(3):363-6. PubMed ID: 16859125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SMAD4 feedback regulates the canonical TGF-β signaling pathway to control granulosa cell apoptosis.
    Du X; Pan Z; Li Q; Liu H; Li Q
    Cell Death Dis; 2018 Feb; 9(2):151. PubMed ID: 29396446
    [TBL] [Abstract][Full Text] [Related]  

  • 32. TGF-beta signaling is disrupted in endometrioid-type endometrial carcinomas.
    Piestrzeniewicz-Ulanska D; Brys M; Semczuk A; Rechberger T; Jakowicki JA; Krajewska WM
    Gynecol Oncol; 2004 Oct; 95(1):173-80. PubMed ID: 15385128
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expression of TGF-beta1, TbetaRII and Smad4 in colorectal carcinoma.
    Xu WQ; Jiang XC; Zheng L; Yu YY; Tang JM
    Exp Mol Pathol; 2007 Jun; 82(3):284-91. PubMed ID: 17289018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Involvement of SMAD4, but not of SMAD2, in transforming growth factor-beta1-induced trophoblast expression of matrix metalloproteinase-2.
    Lin HY; Yang Q; Wang HM; Qi JG; Zhang H; Wang HX; Tsang BK; Zhu C
    Front Biosci; 2006 Jan; 11():637-46. PubMed ID: 16146757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of transforming growth factor-beta1-smad signal transduction pathway in patients with hepatocellular carcinoma.
    Ji GZ; Wang XH; Miao L; Liu Z; Zhang P; Zhang FM; Yang JB
    World J Gastroenterol; 2006 Jan; 12(4):644-8. PubMed ID: 16489684
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic factors for idiopathic pulmonary fibrosis: clinical, physiologic, pathologic, and molecular aspects.
    Lee SH; Shim HS; Cho SH; Kim SY; Lee SK; Son JY; Jung JY; Kim EY; Lim JE; Lee KJ; Park BH; Kang YA; Kim YS; Kim SK; Chang J; Park MS
    Sarcoidosis Vasc Diffuse Lung Dis; 2011 Oct; 28(2):102-12. PubMed ID: 22117501
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mutation of TGF-β receptor II facilitates human bladder cancer progression through altered TGF-β1 signaling pathway.
    Bian J; Li B; Zeng X; Hu H; Hong Y; Ouyang H; Zhang X; Wang Z; Zhu H; Lei P; Huang B; Shen G
    Int J Oncol; 2013 Nov; 43(5):1549-59. PubMed ID: 23970096
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High expression of COUP-TF II cooperated with negative Smad4 expression predicts poor prognosis in patients with colorectal cancer.
    Wang C; Zhou Y; Ruan R; Zheng M; Han W; Liao L
    Int J Clin Exp Pathol; 2015; 8(6):7112-21. PubMed ID: 26261604
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SMAD2/3 mediate oncogenic effects of TGF-β in the absence of SMAD4.
    Bertrand-Chapel A; Caligaris C; Fenouil T; Savary C; Aires S; Martel S; Huchedé P; Chassot C; Chauvet V; Cardot-Ruffino V; Morel AP; Subtil F; Mohkam K; Mabrut JY; Tonon L; Viari A; Cassier P; Hervieu V; Castets M; Mauviel A; Sentis S; Bartholin L
    Commun Biol; 2022 Oct; 5(1):1068. PubMed ID: 36207615
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Smad signaling pathway is a pivotal component of tissue inhibitor of metalloproteinases-3 regulation by transforming growth factor beta in human chondrocytes.
    Qureshi HY; Ricci G; Zafarullah M
    Biochim Biophys Acta; 2008 Sep; 1783(9):1605-12. PubMed ID: 18471442
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.